SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Thursday reported a loss of $129.4 million in its third quarter.
The South San Francisco, California-based company said it had a loss of $1.35 per share.
The results missed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 72 cents per share.
The biopharmaceutical company posted revenue of $378,000 in the period, which also fell short of Street forecasts. Nine analysts surveyed by Zacks expected $24.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK
